Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR ...

Even gene drives aimed at controlling malaria-carrying mosquitoes rely on CRISPR’s precision. Among CRISPR’s many variants, the compact Type V Cas12 enzymes—key players in genome editing, diagnostics, ...

The biotech industry is almost always buzzing. However, there has been some unanticipated activity in this sector of late.

CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

Natural systems such as CRISPR-associated transposons (CASTs) offer a targetable, one-step way to edit genomes. However, ...

That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...

Over the past few decades, biomedical researchers and neuroscientists have devised increasingly advanced techniques to study ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $61.67, marking a +2.24% move from the previous day.